![](https://i0.wp.com/shacklemedia.com/wp-content/uploads/2023/11/novo-nordisk-earnings-surge-it-cant-make-weight-loss-drugs-fast-enough.jpg?w=640&ssl=1)
Novo Nordisk reported a surge in earnings and revenue on Thursday as it continues to benefit from the popularity of its weight-loss drugs. However, the company is still struggling with raising the supply of the drugs to meet demand.
Source: finance.yahoo.com
Related posts:
Sony and Apollo move ahead with Paramount bid process but reticent about earlier plan, NYT reports
Will The Stock Market Crash Soon? This Leading Indicator Says Not Yet
Should you do a Roth IRA conversion now? Yes, if you’re in this ‘holy grail’ group.
Even 'Bond King' Bill Gross is getting in on Trump Media's options-trading frenzy
2 Stocks Flashing Signs of Strong Insider Buying and Analyst Support